Brian Walitt

TL;DR: A (2016) revision to the 2010/2011 fibromyalgia criteria combines physician and questionnaire criteria, minimizes misclassification of regional pain disorders, and eliminates the previously confusing recommendation regarding diagnostic exclusions.

TL;DR: Examination of the surrogate polysymptomatic distress scale (PSD) of the 2010 ACR criteria found fibromyalgia symptoms extending through the full length of the scale with physiological as well as mental stressors suggests PSD may be a universal response variable rather than one restricted to Fibromyalgia.

TL;DR: The perception of fibromyalgia as almost exclusively a women’s disorder is not supported by data in unbiased studies, and the use of 2016 fibromy nostalgia criteria for clinical diagnosis and epidemiology is recommended because of its updated scoring and generalized pain requirement.

TL;DR: It is hypothesized that the administration of chemotherapy agents initiates a cascade of biological changes, with short-lived alterations in the cytokine milieu inducing persistent epigenetic alterations that lead to changes in gene expression, alterations in metabolic activity and neuronal transmission responsible for generating the subjective experience of cognition.

TL;DR: Study results indicate that multiple, inter‐correlated factors that include social disadvantage, psychological distress, comorbidity, RA severity, and fibromyalgia variables predict future development of fibromyalgia, but there is little evidence of the effect of underlying causes.